Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc transporter 3 (ZnT3; SLC30A3) is a membrane protein of the solute carrier 30 family responsible for transporting zinc from the cytosol into synaptic vesicles and lysosomes, thereby reducing cytoplasmic free zinc concentrations and maintaining zinc homeostasis, especially in the brain[1][2][3]. It is highly expressed in neurons, particularly in the brain where it enables zinc accumulation in synaptic vesicles, and plays a crucial role in synaptic transmission and neurological function[1][3][5]. ZnT3 functions as a probable proton-coupled zinc antiporter, supporting zinc sequestration into intracellular organelles in exchange for protons[3]. Dysregulation or knockout of ZnT3 significantly impairs zinc storage in synaptic vesicles and may be implicated in conditions such as epilepsy and neurodegenerative diseases[3][4][5]. While it is experimentally valuable, drugs specifically targeting ZnT3 are not clinically established and direct pharmacological modulation is not reported in the literature as of yet.
Zinc ion antiport against protons (proton-coupled zinc transport)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc transporter 3 (ZnT3 (SLC30A3)).